Literature DB >> 10216489

The secretion of cytokines and granulocyte colony stimulating factor by anaplastic and poorly differentiated thyroid carcinoma cell lines.

H Asakawa1, T Kobayashi.   

Abstract

BACKGROUND: Thyroid tumors exhibit a wide spectrum of histopathology and some thyroid carcinomas are reported to secrete various cytokines. However, it is obscure whether the differentiation of thyroid carcinoma is related to amount and variety of the secreted cytokines or how the secreted cytokines affect patients. We examined the secretion of cytokines and G-CSF in four anaplastic (K119, IAA, KOA2 and MSA) and two poorly differentiated (SMP and CTP) thyroid carcinoma cell lines and compared them with the clinical courses of patients.
MATERIALS AND METHODS: We collected conditioned medium from each of the cell lines and measured the release of cytokines (IL-1 alpha, IL-1 beta, IL-6, IL-8 and TNF-alpha) and growth factors (G-CSF, IGF-1) by each assay kits. IL-1 alpha, IL-8 and TNF-alpha were measured by ELISA. G-CSF was measured by one step sandwich EIA method. IL-1 beta and IGF-1 were measured by immunoradiometric assay. IL-6 was measured by chemiluminescent enzyme immunoassay.
RESULTS: All four anaplastic and one poorly differentiated (SMP) thyroid cell lines secreted G-CSF and all examined cytokines except TNF-alpha. One poorly differentiated (CTP) thyroid cell line secreted IL-1 beta, IL-6 and IL-8. IGF-1 and TNF-alpha were not detected in all examined conditioned medium of cell lines. All four original patients with anaplastic thyroid carcinoma showed remarkable leukocytosis at terminal stage and in one of these patients, subfever without any infections was observed.
CONCLUSION: Anaplastic and poorly differentiated thyroid carcinomas have the ability to secrete various cytokines and G-CSF, which may affect clinical symptoms of the patients at terminal stage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216489

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  VEGF and GM-CSF levels in nodular thyroid diseases.

Authors:  Birsen Bilgici; Gulcin C Ecemis; Ozgur K Tuncel; Ilkay K Bayrak; Elif K Kan; Aysegul Atmaca
Journal:  Endocrine       Date:  2013-04-28       Impact factor: 3.633

2.  Granulocyte colony-stimulating factor-producing cholangiocellular carcinoma.

Authors:  Kazuhiro Suzumura; Yuji Iimuro; Tadamichi Hirano; Yasukane Asano; Nobukazu Kuroda; Toshihiro Okada; Shogo Tanaka; Keiji Nakasho; Jiro Fujimoto
Journal:  Int Surg       Date:  2015-01

3.  Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: report of a case.

Authors:  Kazunori Shimada; Kazuhiro Iwase; Toyokazu Aono; Sumio Nakai; Shin-ichi Takeda; Makoto Fujii; Masaru Koma; Kazuhiro Nishikawa; Chu Matsuda; Masashi Hirota; Hiroaki Fushimi; Yasuhiro Tanaka
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

4.  Granulocyte-colony stimulating factor-producing gallbladder carcinoma.

Authors:  Kazuhiro Suzumura; Yuji Iimuro; Yasukane Asano; Nobukazu Kuroda; Tadamichi Hirano; Junichi Yamanaka; Toshihiro Okada; Tomohiro Okamoto; Ikuko Torii; Jiro Fujimoto
Journal:  Int Surg       Date:  2014 Sep-Oct

5.  Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion.

Authors:  Francesca Coperchini; Patrizia Pignatti; Paola Leporati; Andrea Carbone; Laura Croce; Flavia Magri; Luca Chiovato; Mario Rotondi
Journal:  Endocrine       Date:  2015-10-08       Impact factor: 3.633

Review 6.  IGF Bioregulation System in Benign and Malignant Thyroid Nodular Disease: A Systematic Review.

Authors:  Apostolos Karagiannis; Eva Kassi; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.